Söndag 22 December | 09:39:43 Europe / Stockholm

Kalender

Tid*
2025-08-28 08:00 Kvartalsrapport 2025-Q2
2025-04-04 N/A Årsstämma
2025-03-07 08:00 Bokslutskommuniké 2024
2024-08-29 - Kvartalsrapport 2024-Q2
2024-04-05 - X-dag ordinarie utdelning AIFORIA 0.00 EUR
2024-04-04 - Årsstämma
2024-03-07 - Bokslutskommuniké 2023
2023-08-25 - Kvartalsrapport 2023-Q2
2023-03-31 - X-dag ordinarie utdelning AIFORIA 0.00 EUR
2023-03-30 - Årsstämma
2023-03-02 - Bokslutskommuniké 2022
2022-08-25 - Kvartalsrapport 2022-Q2
2022-04-06 - X-dag ordinarie utdelning AIFORIA 0.00 EUR
2022-04-05 - Årsstämma
2022-03-02 - Bokslutskommuniké 2021

Beskrivning

LandFinland
ListaFirst North Finland
SektorInformationsteknik
IndustriProgramvara
Aiforia Technologies utrustar patologer och forskare i prekliniska och kliniska laboratorier med programvara för att översätta bilder till upptäckter, beslut och diagnoser. Bolagets produkter och tjänster används för medicinsk bildanalys, över en mängd olika områden från onkologi till neurovetenskap. Aiforia Technologies har sitt huvudkontor i Finland.
2024-09-26 14:20:00

Aiforia Technologies Plc, Company release, Managers’ Transactions, September 26, 2024 03:20 p.m. EEST

Aiforia Technologies Plc – Managers' Transactions

____________________________________________

Person subject to the notification requirement

Name: Panu Kauppila

Position: Other senior manager

Issuer: Aiforia Technologies Oyj

LEI: 743700TJRVBX7420Y723

Notification type: INITIAL NOTIFICATION

Reference number: 78987/5/4

____________________________________________

 

Transaction date: 2024-09-25

Outside a trading venue

Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT

Name of the instrument: Aiforia Technologies Oyj 2024 Options

Nature of transaction: ACCEPTANCE OF A STOCK OPTION

(X) Made under life insurance policy

 

Transaction details (1):

Volume: 50000 Unit price: 0 EUR

 

Aggregated transactions (1):

Volume: 50000 Volume weighted average price: 0 EUR

 

Further inquiries

Veli-Matti Parkkonen, CFO, Aiforia Technologies Plc

tel. +358405009878

https://investors.aiforia.com/

 

Certified Adviser

UB Corporate Finance Ltd

ubcf@unitedbankers.fi

 

About Aiforia

Aiforia is a trusted provider of deep learning artificial intelligence (AI) solutions for pathology. Aiforia delivers software solutions that elevate diagnostic capabilities in image analysis, enabling remarkable medical discoveries now and in the future. With thousands of AI models already developed on the Aiforia platform for research use and several diagnostic solutions deployed, Aiforia is already significantly impacting pathology and healthcare.

Founded in 2013, Aiforia is a publicly traded company operating internationally with thousands of platform users across the globe. The company is headquartered in Helsinki, Finland, with offices in Cambridge, Massachusetts, and Rochester, Minnesota, and local representatives across Europe and North America. The diverse team at Aiforia includes experienced pathologists, medical scientists, AI and software developers, and a dedicated commercial team. Together, they are working to transform pathology with AI, enabling better care for each patient.

Find out more at www.aiforia.com